Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Merck Expects Expedited Filing Of HDL-Cholesterol Drugs Using Existing Data

Executive Summary

Merck believes it will be able to submit its developmental atherosclerosis therapies targeting HDL cholesterol without conducting major outcomes trials, Merck Research Lab President Peter Kim said during the firm's annual business review in Whitehouse Station, N.J. Dec. 15

You may also be interested in...



Merck To Improve R&D Output By Having More Clues At The Start

Merck's strategy for increasing its research and development productivity relies upon gaining more information about compounds and targets earlier in development, Merck Research Labs President Peter Kim said Dec. 12

Merck To Improve R&D Output By Having More Clues At The Start

Merck's strategy for increasing its research and development productivity relies upon gaining more information about compounds and targets earlier in development, Merck Research Labs President Peter Kim said Dec. 12

Merck To Await Additional Torcetrapib Data Before Advancing CETP Agent

Merck will await further data regarding Pfizer's terminated HDL/LDL compound torcetrapib/Lipitor before moving forward with its own cholesteryl ester transfer protein inhibitor

Related Content

Topics

UsernamePublicRestriction

Register

PS046684

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel